Androgens and erectile function: a case for early androgen use in postprostatectomy hypogonadal men

Area of Science:

• Urology
• Andrology
• Sexual Medicine

Background:

• Erectile dysfunction (ED) affects up to 80% of men post-radical prostatectomy (RP).
• Hypogonadal men are often not treated with testosterone post-RP due to unfounded fears of stimulating prostate cancer.
• Emerging data supports testosterone's role in enhancing erectile recovery after RP.

Purpose of the Study:

• To explore the relationship between testosterone replacement therapy (TRT) and erectile preservation following RP.
• To evaluate the existing literature on testosterone's role in erectile function post-RP.

Main Methods:

• Literature review of findings on testosterone's association with erectile function.
• Evaluation of studies demonstrating testosterone's role in erections and preservation.
• Specific assessment of testosterone's role in erectile preservation after RP.

Main Results:

• Testosterone plays a significant role in erectile function, especially post-RP.
• Testosterone influences nitric oxide synthase, phosphodiesterase type 5, and cavernosal nerve function.
• Testosterone contributes to mechanisms crucial for erectile preservation in RP patients.

Conclusions:

• The established link between TRT and improved erectile function may be more critical post-RP.
• Further research is necessary to confirm the safety of TRT in the context of RP.